Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Nice Read
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(577)
•••
Comment by Quattro74on Jun 18, 2020 10:43pm
229 Views
Post# 31167700

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nice Read

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nice Read
Yep, definetely withdrawals. MLB is a bad omen for TLT right now. :-( Once ~ 50-60 patients have their 90 day CR data in and the first few of the 12 have their 1Yr CR data, should get interesting for SP. Especially since a good cunk of those patients will be US based.  $$$

CAinPlap wrote: Yup we are hitting home runs in spring training batting practice where no one sees it but the training staff. We need the regular season to start where the games are televised, fans in the stands and post game coverage by the media. Based on our spring training results, we should be World Series favorites! ;)
This analogy brought to you by the sports fan withdrawal support group.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities